
Episodes
Podcast: What you need to know about apomorphine pump treatment for Parkinson’s disease
Three guests share their unique perspectives on the treatment
READ MOREThe incidence of mutated genes that can develop into Parkinson’s disease in Jews is being researched by The Michael J Fox Foundation.
The biggest genetic indicator of Parkinson’s is 10 times more prevalent in Ashkenazi Jews than in the general population, research has revealed.
A new global study will track how often mutated LRRK2 genes – which are present in 10 per cent of Ashkenazim – develops into the disease. A second mutated gene called GBA was also found to be more common in this ethnic group. A saliva test can show whether a patient has these mutated genes.
Gemma Loebenberg, a specialist at the National Institute of Health Research, which leads this investigation, said: “People who have one of those genes have a 50 per cent chance of passing it to their children.”
She called on Jews with Parkinson’s, or who have relatives with the condition, to volunteer for the study.
Three guests share their unique perspectives on the treatment
READ MORELeslie Davidson discusses her and her husband’s simultaneous diagnoses
READ MOREThe annual Parkinson’s fundraiser in Denmark
READ MORE
Comments